Anhui Anke Biotechnology (Group) Statistics

Total Valuation

Anhui Anke Biotechnology (Group) has a market cap or net worth of CNY 13.95 billion. The enterprise value is 12.93 billion.

Market Cap	13.95B
Enterprise Value	12.93B

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Anhui Anke Biotechnology (Group) has 1.67 billion shares outstanding. The number of shares has increased by 0.64% in one year.

Current Share Class	n/a
Shares Outstanding	1.67B
Shares Change (YoY)	+0.64%
Shares Change (QoQ)	+4.41%
Owned by Insiders (%)	37.93%
Owned by Institutions (%)	10.32%
Float	1.04B

Valuation Ratios

The trailing PE ratio is 17.80.

PE Ratio	17.80
Forward PE	n/a
PS Ratio	5.04
PB Ratio	3.66
P/TBV Ratio	4.04
P/FCF Ratio	23.41
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.92, with an EV/FCF ratio of 21.70.

EV / Earnings	16.52
EV / Sales	4.67
EV / EBITDA	13.92
EV / EBIT	15.81
EV / FCF	21.70

Financial Position

The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.01.

Current Ratio	3.20
Quick Ratio	2.66
Debt / Equity	0.01
Debt / EBITDA	0.06
Debt / FCF	0.09
Interest Coverage	300.63

Financial Efficiency

Return on equity (ROE) is 20.21% and return on invested capital (ROIC) is 12.86%.

Return on Equity (ROE)	20.21%
Return on Assets (ROA)	10.67%
Return on Capital (ROIC)	12.86%
Revenue Per Employee	926,205
Profits Per Employee	262,068
Employee Count	2,986
Asset Turnover	0.58
Inventory Turnover	2.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.86% in the last 52 weeks. The beta is 0.56, so Anhui Anke Biotechnology (Group)'s price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	-16.86%
50-Day Moving Average	9.09
200-Day Moving Average	9.05
Relative Strength Index (RSI)	31.38
Average Volume (20 Days)	14,983,836

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Anhui Anke Biotechnology (Group) had revenue of CNY 2.77 billion and earned 782.53 million in profits. Earnings per share was 0.47.

Revenue	2.77B
Gross Profit	2.15B
Operating Income	817.71M
Pretax Income	850.43M
Net Income	782.53M
EBITDA	921.05M
EBIT	817.71M
Earnings Per Share (EPS)	0.47

Full Income Statement

Balance Sheet

The company has 1.27 billion in cash and 55.76 million in debt, giving a net cash position of 1.21 billion or 0.73 per share.

Cash & Cash Equivalents	1.27B
Total Debt	55.76M
Net Cash	1.21B
Net Cash Per Share	0.73
Equity (Book Value)	4.13B
Book Value Per Share	2.28
Working Capital	1.54B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 748.05 million and capital expenditures -152.31 million, giving a free cash flow of 595.74 million.

Operating Cash Flow	748.05M
Capital Expenditures	-152.31M
Free Cash Flow	595.74M
FCF Per Share	0.36

Full Cash Flow Statement

Margins

Gross margin is 77.62%, with operating and profit margins of 29.57% and 28.29%.

Gross Margin	77.62%
Operating Margin	29.57%
Pretax Margin	30.75%
Profit Margin	28.29%
EBITDA Margin	33.30%
EBIT Margin	29.57%
FCF Margin	21.54%

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 2.99%.

Dividend Per Share	0.25
Dividend Yield	2.99%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	52.83%
Buyback Yield	-0.64%
Shareholder Yield	2.35%
Earnings Yield	5.62%
FCF Yield	4.27%

Dividend Details

Stock Splits

The last stock split was on May 14, 2021. It was a forward split with a ratio of 1.2.

Last Split Date	May 14, 2021
Split Type	Forward
Split Ratio	1.2

Scores

Anhui Anke Biotechnology (Group) has an Altman Z-Score of 13.02.

Altman Z-Score	13.02
Piotroski F-Score	n/a